BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15068000)

  • 61. Chronic hepatitis B: divide and conquer?
    Nassal M
    Gut; 2018 Mar; 67(3):400-402. PubMed ID: 28706078
    [No Abstract]   [Full Text] [Related]  

  • 62. Immunotolerant Chronic Hepatitis B Infection: When Do I Treat?
    Kumar S; Ramachandran TM
    J Clin Exp Hepatol; 2019; 9(2):277-279. PubMed ID: 31024211
    [No Abstract]   [Full Text] [Related]  

  • 63. Management of patients with HIV and/or hepatitis.
    Lee CA
    Haemophilia; 1995 Jan; 1 Suppl 1():26-34. PubMed ID: 27214737
    [No Abstract]   [Full Text] [Related]  

  • 64. Treatment options for hepatitis B.
    Conly J; Johnston B
    Can J Infect Dis Med Microbiol; 2007 May; 18(3):173-6. PubMed ID: 18923722
    [No Abstract]   [Full Text] [Related]  

  • 65. Occult hepatitis B virus infection among human immunodeficiency virus-infected patients with isolated hepatitis B core antibody in Isfahan, Iran.
    Khorvash F; Javadi A; Tayeri K; Ataei B
    J Res Med Sci; 2014 Mar; 19(Suppl 1):S64-6. PubMed ID: 25002898
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical perspectives of emerging pathogens in bleeding disorders.
    Ludlam CA; Powderly WG; Bozzette S; Diamond M; Koerper MA; Kulkarni R; Ritchie B; Siegel J; Simmonds P; Stanley S; Tapper ML; von Depka M
    Lancet; 2006 Jan; 367(9506):252-61. PubMed ID: 16427495
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antiretroviral therapy and HIV/hepatitis B virus coinfection.
    Benhamou Y
    Clin Infect Dis; 2004 Mar; 38 Suppl 2():S98-103. PubMed ID: 14986281
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future.
    Núñez M; Puoti M; Camino N; Soriano V
    Clin Infect Dis; 2003 Dec; 37(12):1678-85. PubMed ID: 14689351
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Editorial comment: HIV and HBV coinfection--a coming-of-age in treatment strategies.
    Ala A; Dieterich DT
    AIDS Read; 2004 Mar; 14(3):134-5. PubMed ID: 15068001
    [No Abstract]   [Full Text] [Related]  

  • 70. Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.
    Ristig MB; Crippin J; Aberg JA; Powderly WG; Lisker-Melman M; Kessels L; Tebas P
    J Infect Dis; 2002 Dec; 186(12):1844-7. PubMed ID: 12447773
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Management of chronic hepatitis B in the HIV-infected patient.
    Thio CL
    AIDS Read; 2004 Mar; 14(3):122-9, 133, 136-7. PubMed ID: 15068000
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HIV and hepatitis B virus: options for managing coinfection.
    Dieterich DT
    Top HIV Med; 2003; 11(1):16-9. PubMed ID: 12717046
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.